Equine sFlt-1 antibody and antigen (recombinant protein)
Diagnostic anti-Equine sFlt-1 antibodies pairs and antigen for animal health (animal Equine/Horse ascular diseases and cancer) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-EQU-sFlt-1-Ag01 | Recombinant Equine sFlt-1 protein | 3090 |
GMP-EQU-sFlt-1-Ab01 | Anti-Equine sFlt-1 mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-sFlt-1-Ab02 | Anti-Equine sFlt-1 mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-sFlt-1-Ab03 | Anti-Equine sFlt-1 human monoclonal antibody (mAb) | 1953 |
GMP-EQU-sFlt-1-Ab04 | Anti-Equine sFlt-1 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-EQU-sFlt-1-Ag01 |
Product Name | Recombinant Equine sFlt-1 protein |
Target/Biomarker | Equine soluble vascular endothelial growth factor receptor-1 (sFlt-1) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Equine soluble vascular endothelial growth factor receptor-1 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in sFlt-1 level test of animal Equine/Horse with ascular diseases and cancer. |
Tag | His |
Products description | Recombinant Equine sFlt-1 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-sFlt-1-Ab01, GMP-EQU-sFlt-1-Ab02 |
Product Name | Anti-Equine sFlt-1 mouse monoclonal antibody (mAb) |
Target/Biomarker | Equine soluble vascular endothelial growth factor receptor-1 (sFlt-1) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Equine soluble vascular endothelial growth factor receptor-1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-sFlt-1 antibodies in sFlt-1 level test of animal Equine/Horse with ascular diseases and cancer. |
Tag | mFc |
Products description | Anti-Equine sFlt-1 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-sFlt-1 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-sFlt-1-Ab03, GMP-EQU-sFlt-1-Ab04 |
Product Name | Anti-Equine sFlt-1 human monoclonal antibody (mAb) |
Target/Biomarker | Equine soluble vascular endothelial growth factor receptor-1 (sFlt-1) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Equine soluble vascular endothelial growth factor receptor-1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-sFlt-1 antibodies in sFlt-1 level test of animal Equine/Horse with ascular diseases and cancer. |
Tag | hFc |
Products description | Anti-Equine sFlt-1 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-sFlt-1 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Soluble Fms-Like Tyrosine Kinase-1 (sFlt-1) in horses (equines) is a pivotal biomarker with multifaceted roles in vascular health and angiogenesis regulation. It is a soluble receptor that plays a critical role in regulating the formation of new blood vessels (angiogenesis) and maintaining vascular homeostasis. Structurally, sFlt-1 is a truncated form of the transmembrane receptor, Fms-like tyrosine kinase-1 (Flt-1), which is involved in binding vascular endothelial growth factor (VEGF) and placental growth factor (PlGF). In healthy adult horses, sFlt-1 levels are typically tightly regulated to contribute to the maintenance of normal vascular function. It serves as a decoy receptor, sequestering VEGF and PlGF and preventing them from binding to their cellular receptors. This regulation is crucial for preventing excessive angiogenesis and ensuring proper vascular function.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.